Goal-Directed Fluid Therapy in Patients Undergoing Lower Limb Surgeries

NCT ID: NCT06133257

Last Updated: 2023-11-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-01

Study Completion Date

2024-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Controlling the amount of fluids given to patients in perioperative setting can significantly influence their outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To overcome these problems and avoid the complications of over or underhydration, we use the Goal-directed fluid therapy(GDFT) guided by Inferior vena cava(IVC) collapsibility index approach in which dynamic parameters of volume responsiveness as a guide for fluid therapy. This will ensure that the fluids given were deficient from the circulation and improve the recovery of the patients according to enhanced recovery after surgery(ERAS) protocols.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia ERAS Fluid Overload Hypovolemia; Surgical Shock

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GD Group

Patients will take oral clear fluids with carbohydrates content 2 hours preoperatively and intraoperative fluid intake will be guided by Inferior vena cava(IVC) diameter.

Group Type ACTIVE_COMPARATOR

Goal-Directed Fluid Therapy guided by Inferior Vena Cava Collapsibility Index

Intervention Type PROCEDURE

Measuring Inferior vena cava(IVC) diameter using ultrasound then calculation Inferior vena cava(IVC) collapsibility index and administer fluid accordingly.

C Group

the standard fluid management group patients will be fasting 6 hours preoperatively and will receive intraoperative fluid in standard manner.

Group Type ACTIVE_COMPARATOR

standard fluid management

Intervention Type PROCEDURE

standard fluid management

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Goal-Directed Fluid Therapy guided by Inferior Vena Cava Collapsibility Index

Measuring Inferior vena cava(IVC) diameter using ultrasound then calculation Inferior vena cava(IVC) collapsibility index and administer fluid accordingly.

Intervention Type PROCEDURE

standard fluid management

standard fluid management

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient's acceptance.
* Patients planned for elective lower limb surgery under spinal anesthesia.
* Both sexes
* Body Mass Index(BMI): \<35
* Age: 21 \~ 65 years
* American Society of Anesthesiologists(ASA) Physical Status Classification System: Class I \& II
* Duration of surgery 2\~3 hours

Exclusion Criteria

* Advanced kidney, liver, respiratory or cardiovascular disease.
* Contraindication for spinal anesthesia.
* Patients shifted to general anesthesia for any reason.
Minimum Eligible Age

21 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zagazig University

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mahmoud Aboubakr Abdelkader

resident doctor of anesthesia, Intensive Care and Pain Management

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mahmoud Abdelkader, MBBCh

Role: PRINCIPAL_INVESTIGATOR

Anesthesia, Intensive Care and Pain Management department, Faculty of Medicine, Zagazig University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mahmoud Abdelkader, MBBCh

Role: CONTACT

00201553638376

Alshaimaa Kamel, MD.

Role: CONTACT

01005593169 ext. 002

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

11122

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.